The National Institute for Clinical Excellence is to rule on whether a range of anti-cancer drugs should be available on the NHS. Health minister John Denham has referred a series of treatments to NICE, in a two-year programme. The list covers therapies for lung, colorectal, blood, breast, ovarian, brain and ...